Description

TOFISIGN 100 TABLET contains Tofisopam 100 mg, a benzodiazepine derivative classified as a 2,3-benzodiazepine, known for its anxiolytic, nootropic, and antidepressant-like effects—without the sedative, muscle-relaxant, or anticonvulsant actions commonly seen with traditional benzodiazepines.

Unlike conventional anti-anxiety agents, TOFISIGN 100 does not impair motor coordination or induce sedation, making it particularly useful for daytime administration in patients requiring clear cognitive function.

Anxiolytic – Non-sedative Benzodiazepine Derivative

Tofisopam modulates the central nervous system by acting on specific GABA-A receptor subtypes (distinct from traditional benzodiazepines). It helps restore balance in brain neurotransmission, reducing psychological tension without causing drowsiness or dependency.

• Generalized Anxiety Disorder (GAD)

• Psychosomatic Disorders

• Stress-Related Functional GI Disorders

• Panic Disorders

• Alcohol withdrawal-related anxiety (supportive therapy)

• Effectively controls anxiety and stress symptoms

• Non-sedative, non-hypnotic, and preserves daytime alertness

• Minimal risk of dependency with short-term use

• Enhances cognitive stability and emotional control

• Can be combined with antidepressants or gastrointestinal agents

• Usual adult dose: 50–100 mg, two to three times daily, based on severity and physician’s recommendation

• Should be taken after meals to improve absorption and reduce gastrointestinal side effects

• Short-term use recommended; regular monitoring for efficacy and tolerance advised

• Not recommended for long-term continuous use without physician supervision

• Should be avoided in patients with severe liver impairment or a history of substance abuse

• Caution in pregnancy and lactation unless advised by a healthcare provider

• Do not combine with alcohol or sedatives unless medically advised

• Mild headache

• Dizziness or lightheadedness

• Gastrointestinal discomfort

• Rarely, allergic reactions or mood changes

BLUEPILL EXPRESS, a global exporter of high-quality pharmaceuticals, ensures that TOFISIGN 100 TABLET is manufactured under strict GMP-compliant conditions. Our supply chain and QA/QC protocols ensure purity, potency, and consistency in every batch.

We support:

• Custom branding for international partners

• Regulatory dossiers including COA, MSDS, and stability data

• Fast-track shipping across Latin America, Asia, CIS, and Africa

• Competitive pricing for bulk orders

As a leading third-party pharmaceutical manufacturer and exporter, BLUEPILL EXPRESS supplies TOFISIGN 100 TABLET to markets across:

• Southeast Asia

• Africa and Middle East

• Latin America

• CIS countries

• European regions under regulatory compliance